UA83852U - Фармацевтическая композиция для изготовления лекарственных средств, предназначенных для лечения заболеваний носоглотки - Google Patents
Фармацевтическая композиция для изготовления лекарственных средств, предназначенных для лечения заболеваний носоглотки Download PDFInfo
- Publication number
- UA83852U UA83852U UAU201308477U UAU201308477U UA83852U UA 83852 U UA83852 U UA 83852U UA U201308477 U UAU201308477 U UA U201308477U UA U201308477 U UAU201308477 U UA U201308477U UA 83852 U UA83852 U UA 83852U
- Authority
- UA
- Ukraine
- Prior art keywords
- pharmaceutical composition
- miramistin
- nasopharynx
- water
- treatment
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title claims abstract description 20
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 5
- 208000015386 nasopharyngeal disease Diseases 0.000 title claims abstract description 4
- 239000002552 dosage form Substances 0.000 title abstract 2
- JQQZCIIDNVIQKO-UHFFFAOYSA-N benzyl-dimethyl-[3-(tetradecanoylamino)propyl]azanium;chloride Chemical compound [Cl-].CCCCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC1=CC=CC=C1 JQQZCIIDNVIQKO-UHFFFAOYSA-N 0.000 claims abstract description 22
- SONNWYBIRXJNDC-VIFPVBQESA-N phenylephrine Chemical compound CNC[C@H](O)C1=CC=CC(O)=C1 SONNWYBIRXJNDC-VIFPVBQESA-N 0.000 claims abstract description 14
- 229960001802 phenylephrine Drugs 0.000 claims abstract description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 13
- 150000003839 salts Chemical class 0.000 claims abstract description 10
- 239000007921 spray Substances 0.000 claims abstract description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 6
- 208000027866 inflammatory disease Diseases 0.000 claims description 6
- 210000001989 nasopharynx Anatomy 0.000 claims description 4
- 230000003612 virological effect Effects 0.000 claims description 4
- 229920002678 cellulose Polymers 0.000 claims description 3
- 239000001913 cellulose Substances 0.000 claims description 3
- 230000000813 microbial effect Effects 0.000 claims description 3
- 239000011780 sodium chloride Substances 0.000 claims description 3
- 229940126601 medicinal product Drugs 0.000 claims 1
- 239000003814 drug Substances 0.000 description 16
- 229940079593 drug Drugs 0.000 description 13
- 239000013543 active substance Substances 0.000 description 5
- 210000002345 respiratory system Anatomy 0.000 description 5
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 230000002421 anti-septic effect Effects 0.000 description 3
- 239000000850 decongestant Substances 0.000 description 3
- 210000004400 mucous membrane Anatomy 0.000 description 3
- 230000001154 acute effect Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000000845 anti-microbial effect Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 210000004379 membrane Anatomy 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 230000009885 systemic effect Effects 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000003501 anti-edematous effect Effects 0.000 description 1
- 229940124599 anti-inflammatory drug Drugs 0.000 description 1
- 229940064004 antiseptic throat preparations Drugs 0.000 description 1
- 239000003443 antiviral agent Substances 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 231100000315 carcinogenic Toxicity 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000001886 ciliary effect Effects 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 238000013467 fragmentation Methods 0.000 description 1
- 238000006062 fragmentation reaction Methods 0.000 description 1
- 231100000024 genotoxic Toxicity 0.000 description 1
- 230000001738 genotoxic effect Effects 0.000 description 1
- 208000024798 heartburn Diseases 0.000 description 1
- 210000005260 human cell Anatomy 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 230000000420 mucociliary effect Effects 0.000 description 1
- 210000003928 nasal cavity Anatomy 0.000 description 1
- 210000002850 nasal mucosa Anatomy 0.000 description 1
- 201000009240 nasopharyngitis Diseases 0.000 description 1
- 210000001331 nose Anatomy 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 239000008196 pharmacological composition Substances 0.000 description 1
- 210000003800 pharynx Anatomy 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 208000023504 respiratory system disease Diseases 0.000 description 1
- 206010039083 rhinitis Diseases 0.000 description 1
- -1 salts salt Chemical class 0.000 description 1
- 238000009097 single-agent therapy Methods 0.000 description 1
- 201000009890 sinusitis Diseases 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000003390 teratogenic effect Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 239000005526 vasoconstrictor agent Substances 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Фармацевтическая композиция для изготовления лекарственных средств в форме капель и спреев, предназначенных для лечения заболеваний носоглотки, содержит мирамистин и воду. Она дополнительно содержит фенилэфрин или его фармацевтически приемлемые соли.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UAU201308477U UA83852U (ru) | 2013-07-05 | 2013-07-05 | Фармацевтическая композиция для изготовления лекарственных средств, предназначенных для лечения заболеваний носоглотки |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UAU201308477U UA83852U (ru) | 2013-07-05 | 2013-07-05 | Фармацевтическая композиция для изготовления лекарственных средств, предназначенных для лечения заболеваний носоглотки |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA83852U true UA83852U (ru) | 2013-09-25 |
Family
ID=52279188
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAU201308477U UA83852U (ru) | 2013-07-05 | 2013-07-05 | Фармацевтическая композиция для изготовления лекарственных средств, предназначенных для лечения заболеваний носоглотки |
Country Status (1)
| Country | Link |
|---|---|
| UA (1) | UA83852U (ru) |
-
2013
- 2013-07-05 UA UAU201308477U patent/UA83852U/ru unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2263643T3 (es) | Uso de hidroxietilrutosidos para el tratamiento de los sintomas del r esfriado comun, de la fiebre de heno y de infecciones relacionadas con el tacto respiratorio. | |
| JP6762931B2 (ja) | 経鼻組成物と該経鼻組成物の使用方法の改善 | |
| US20090191288A1 (en) | Composition to Treat Herpes, Pseudomonas, Staph, Hepatitis and Other Infectious Diseases | |
| US20130072532A1 (en) | Topical transdermal dexmedetomidine compositions and methods of use thereof | |
| US9662360B2 (en) | Treatment of herpes, pseudomonas, staph, and hepatitis | |
| EP2429521A2 (en) | Sublingual dexmedetomidine compositions and methods of use thereof | |
| AU2010335594B2 (en) | Synergistic antiviral composition and use thereof | |
| HRP20120798T1 (hr) | Kappa-opijatni agonisti za lijeäśenje dijareja-predominantnog i naizmjeniäśnog sindroma iritabilnog crijeva | |
| CA3043028A1 (en) | Compositions, devices, and methods for the treatment of opioid-receptor-mediated conditions | |
| AU2023202420A1 (en) | Compositions, devices, and methods for the treatment of alcohol use disorder | |
| JPH0269413A (ja) | アレルギー性鼻炎の治療方法 | |
| US20170368059A1 (en) | Use of levocetirizine and montelukast in the treatment of anaphylaxis | |
| HRP20192189T1 (hr) | Doziranja i terapijske primjene l-4-klorokinurenina | |
| US20110257115A1 (en) | Method for treating rhinitis and sinusitis by rhamnolipids | |
| RU2008110933A (ru) | Применение амброксола для лечения риновирусных инфекций | |
| BRPI0711503A2 (pt) | Forma de dosagem em forma de folha para uma preparação farmacêutica, uso de uma combinação de agentes ativos e método para o tratamento terapêutico de um individuo | |
| RU2616520C2 (ru) | Лечение симптомов, связанных с гастропарезом у женщин | |
| US20150111852A1 (en) | 1-Di(sec-butyl)-phosphinoyl-pentane (dapa-2-5) as a topical agent... | |
| ES2972897T3 (es) | Composiciones descongestionantes nasales que comprenden mentol, dexpantenol e hialuronato de sodio | |
| JP6770091B2 (ja) | ニコチン性アセチルコリン受容体アゴニストによる副鼻腔粘膜疾患を処置するための組成物及び方法 | |
| UA83852U (ru) | Фармацевтическая композиция для изготовления лекарственных средств, предназначенных для лечения заболеваний носоглотки | |
| JP2019516797A5 (ru) | ||
| Jorge | Drug absorption through the nasal mucosa: current challenges | |
| Gudzenko et al. | The invention of drugs for pediatrics: reality and prospects | |
| KR20140116105A (ko) | 국소투여형의 연하장애 개선용 의약품 |